Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Missed 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose 12 months ago). The patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: Missed 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date:28-JUL-2025 It was reported that a patient missed the second dose of Shingrix. The inquiry was made to determine whether a patient can still receive the second dose of Shingrix after 12 months had elapsed since the administration of the first dose. Upon callback to store, spoke to pharmacy on duty who provided patient details. No lot or expiration date of dose 1 was available. Pharmacist states she thinks patient received it at another location. Date of administration of dose 1 also unknown. Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.